Clinical Trials
2 trialsNCT01184287 2015-09-02
A Study Of Ranpirnase(OnconaseĀ®) To Pemetrexed Plus Carboplatin In Patients With Non-Squamous Non-Small Cell Lung Cancer
Tamir Biotechnology, Inc.
Phase 2 Withdrawn
NCT00003034 2013-11-06
ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
National Cancer Institute (NCI)
Phase 3 Unknown